Aceprometazine is a is a drug with neuroleptic and anti-histamine properties. Although not widely prescribed, it is used in combination with meprobamate for the treatment of sleep disorders in France under the trade name Mepronizine.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ivabradine | Ivabradine may increase the QTc-prolonging activities of Aceprometazine. |
| Buprenorphine | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Hydrocodone | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Magnesium sulfate | The therapeutic efficacy of Aceprometazine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Mirtazapine | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Orphenadrine | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Rotigotine | Aceprometazine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Aceprometazine. |
| Sodium oxybate | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Thalidomide | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Aceprometazine may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Aceprometazine. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Aceprometazine. |
| Sulpiride | Aceprometazine may increase the antipsychotic activities of Sulpiride. |
| Benzylpenicilloyl polylysine | Aceprometazine may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with Aceprometazine. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Aceprometazine. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aceprometazine. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Aceprometazine. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Aceprometazine. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Aceprometazine. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Aceprometazine. |
| Mequitazine | Aceprometazine may increase the arrhythmogenic activities of Mequitazine. |
| Thiopental | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Thiopental. |
| Metyrosine | The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Aceprometazine. |
| Ethanol | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Aceprometazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Aceprometazine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Fluvoxamine. |
| Duloxetine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Nefazodone. |
| Milnacipran | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Aceprometazine. |
| Indalpine | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Aceprometazine is combined with Alaproclate. |
| Amphetamine | Amphetamine may decrease the sedative activities of Aceprometazine. |
| Phentermine | Phentermine may decrease the sedative activities of Aceprometazine. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of Aceprometazine. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of Aceprometazine. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of Aceprometazine. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of Aceprometazine. |
| Mephentermine | Mephentermine may decrease the sedative activities of Aceprometazine. |
| MMDA | MMDA may decrease the sedative activities of Aceprometazine. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of Aceprometazine. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Aceprometazine. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Aceprometazine. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of Aceprometazine. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of Aceprometazine. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of Aceprometazine. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of Aceprometazine. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of Aceprometazine. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of Aceprometazine. |
| Ritobegron | Ritobegron may decrease the sedative activities of Aceprometazine. |
| Mephedrone | Mephedrone may decrease the sedative activities of Aceprometazine. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of Aceprometazine. |
| Gepefrine | Gepefrine may decrease the sedative activities of Aceprometazine. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of Aceprometazine. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of Aceprometazine. |
| Esmolol | The serum concentration of Esmolol can be increased when it is combined with Aceprometazine. |
| Betaxolol | The serum concentration of Betaxolol can be increased when it is combined with Aceprometazine. |
| Metoprolol | The serum concentration of Metoprolol can be increased when it is combined with Aceprometazine. |
| Atenolol | The serum concentration of Atenolol can be increased when it is combined with Aceprometazine. |
| Timolol | The serum concentration of Timolol can be increased when it is combined with Aceprometazine. |
| Propranolol | The serum concentration of Propranolol can be increased when it is combined with Aceprometazine. |
| Labetalol | The serum concentration of Labetalol can be increased when it is combined with Aceprometazine. |
| Bisoprolol | The serum concentration of Bisoprolol can be increased when it is combined with Aceprometazine. |
| Alprenolol | The serum concentration of Alprenolol can be increased when it is combined with Aceprometazine. |
| Pindolol | The serum concentration of Pindolol can be increased when it is combined with Aceprometazine. |
| Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Aceprometazine. |
| Propafenone | The serum concentration of Propafenone can be increased when it is combined with Aceprometazine. |
| Acebutolol | The serum concentration of Acebutolol can be increased when it is combined with Aceprometazine. |
| Nadolol | The serum concentration of Nadolol can be increased when it is combined with Aceprometazine. |
| Bevantolol | The serum concentration of Bevantolol can be increased when it is combined with Aceprometazine. |
| Practolol | The serum concentration of Practolol can be increased when it is combined with Aceprometazine. |
| Penbutolol | The serum concentration of Penbutolol can be increased when it is combined with Aceprometazine. |
| Oxprenolol | The serum concentration of Oxprenolol can be increased when it is combined with Aceprometazine. |
| Dexpropranolol | The serum concentration of Dexpropranolol can be increased when it is combined with Aceprometazine. |
| Celiprolol | The serum concentration of Celiprolol can be increased when it is combined with Aceprometazine. |
| Nebivolol | The serum concentration of Nebivolol can be increased when it is combined with Aceprometazine. |